Wide Use of Paperless Partograph in Evaluation of Labour

Paperless partograph wide using in labour room as simple tool in evaluation of labour

Completed

Looking for future studies?

Key information

Conditions

Labor Complication Female Urogenital Diseases and Pregnancy Complications Labor Pain Neurologic Manifestations Obstetric Labor Complications Pain Pathological Conditions, Signs and Symptoms Pregnancy Complications Signs and Symptoms Urogenital Diseases

Age range

25 year–35 year

Sex eligibility

Female

Study type

Observational

Primary location

Faculity of Medicine, Asyut, Egypt

About this study

Both world health organization ( WHO) PARTOGRAPH and modified world heath organization (WHO)PARTOGRAPH are too long labour tools in evaluation of labour so we need simple tool in evaluation of labour

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Spontaneous labour
cephalic presentation
pregnant 37 weeks up to full term

Exclusion criteria

mail_presentation
induced labour

Treatment and study plan

Primary outcomes

Progress of labour

Time frame: up to 2 month

Cervical dilated 1 cm each hour

Secondary outcomes

New born

Time frame: up to 1 month

Apgar scor at 1 minute and Apgar scor at 5 minutes

Sponsors and collaborators

Lead sponsor

Assiut University

Other

Registry information

Official study title

Wide Using of Paperless Partograph in Evaluation of Labour

Acronym: labourRecord

Important dates

Study start: 2017
Primary completion: 2017
Study completion: 2017
First posted: Sep 8, 2017
Registry last updated: Sep 8, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed